Indonesia approves emergency use of China's Zifivax Covid-19 vaccine

JAKARTA, Oct 9 (Xinhua): Indonesia's drug and food authority BPOM has announced that it has issued an emergency use authorization (EUA) for the Zifivax Covid-19 vaccine produced by Chinese biopharmaceutical company Anhui Zhifei Longcom.

"Today, BPOM again announces that we have approved a Covid-19 vaccine product under the trade name Zifivax which was developed with a recombinant protein sub-unit platform," BPOM's head Penny Lukito told a virtual press conference.